Chinwe Owunna of Management Sciences for Health (MSH) describes the active surveillance approach used by the US Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program in Swaziland to increase understanding of medicines safety and risk/benefit context for TB and HIV patients.
Video: Meet Chinwe Owunna
Connect with Us
- Dashboard data improves pharmaceutical supply-chain decision-making in Namibia’s public health facilities
- Sustaining SIAPS’ impact: What’s next for pharmaceutical systems strengthening?
- Toward Building Resilient Pharmaceutical Systems: SIAPS Final Report
- Case studies in strengthening pharma systems: Evidence of lasting progress
- Setting the stage for pharmaceutical system reform in Ukraine
- Therapeutics Information and Pharmacovigilance Centre's Analysis of Spontaneous Adverse Events due to Antiretroviral and Other Medicines
The use of antiretrovirals (ARVs) in combination for treating patients with HIV has greatly ameliorated morbidity and mortality by reducing […]
L’objectif de l’outil OSPSANTE est de capturer, de suivre, d’agréger et de diffuser des informations sur les produits de Nutrition […]
SIAPS final report showcases achievements across 46 countries. Interventions are described by intermediate results and health areas and demonstrate how […]